NAP1L2 and inflammatory bowel disease: Besides, when BMSCs were transplanted in mice with experimental inflammatory bowel disease (IBD) or experimental autoimmune encephalomyelitis (EAE), the therapeutic efficacy of BMSCs was significantly decreased after Nap1l2 overexpression.